mechanism of action of glp-1 receptor agonist Agonists For Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH glp-1_analogs [TUSOM | Pharmwiki]
Description
Retatrutide is an investigational first-in-class GIP, GLP-1 and glucagon triple hormone receptor agonist
![mechanism of action of glp-1 receptor agonist Agonists For Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH glp-1_analogs [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/glp1.png?w=600&tok=baf39c)
Some reports have demonstrated that more than 50% of patients with depression experience chronic and recurrent problems throughout their lifetime, and that depressive symptoms can gradually aggravate and lead to suicide if patients are not treated with proper drugs or counseling (Monroe and Harkness, 2005
![mechanism of action of glp-1 receptor agonist Agonists For Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH glp-1_analogs [TUSOM | Pharmwiki]](https://www.bocsci.com/upload/image/mechanism-of-action-of-glp-1-binding-to-glp-1r.jpg)
Eight per cent of the respondents said they were taking a prescription GLP-1 medication
![mechanism of action of glp-1 receptor agonist Agonists For Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH glp-1_analogs [TUSOM | Pharmwiki]](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41569-023-00849-3/MediaObjects/41569_2023_849_Fig1_HTML.png)
AGA Rapid Clinical Practice Update on the Management of Patients Taking GLP-1 Receptor Agonists Prior to Endoscopy: Communication
![mechanism of action of glp-1 receptor agonist Agonists For Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH glp-1_analogs [TUSOM | Pharmwiki]](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12933-014-0142-7/MediaObjects/12933_2014_Article_142_Fig2_HTML.jpg)
Patients should be advised to eat smaller, more frequent meals and avoid high-fat foods, which may exacerbate nausea
Finally, GLP-1 receptor agonists do not seem to affect negatively the cardiovascular risk in patients with T2D, but an ultimate all-clear regarding the risk of cardiovascular events, pancreatitis, or pancreatic cancer, which may be caused by incretin-mimetic drugs, cannot be given as there is scattered evidence for these side effects
![mechanism of action of glp-1 receptor agonist Agonists For Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH glp-1_analogs [TUSOM | Pharmwiki]](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs40620-020-00738-9/MediaObjects/40620_2020_738_Fig1_HTML.png)